James C. Lin

Davis Polk is advising Universal Scientific Industrial (Shanghai) Co., Ltd. on its acquisition of Asteelflash. Under the terms of the transaction agreement, USI will acquire 100% of the…

Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…

Davis Polk advised the initial purchaser in connection with a Rule 144A and Regulation S offering by Sea Limited of $1.15 billion aggregate principal amount of its 1.00% convertible senior…

Davis Polk advised the underwriters on the SEC-registered initial public offering by ECMOHO Limited of 4,375,000 American Depositary Shares for gross proceeds of $43.8 million. Each ADS…

Davis Polk advised 36Kr Holdings Inc. on its SEC-registered initial public offering of 1,380,000 American Depositary Shares for total proceeds of approximately $20 million. Each ADS…

Davis Polk advised Youdao, Inc. on its SEC-registered initial public offering of 5,600,000 American Depositary Shares. Each ADS represents one Class A ordinary share of Youdao. Youdao has…

Davis Polk advised the underwriters on the SEC-registered initial public offering by 9F Inc. of 8,900,000 American Depositary Shares, consisting of 6,750,000 ADSs sold by 9F and 2,150,000…

Davis Polk advised the placement facilitation agents in connection with the placement outside of Mexico of Ps. 1 billion aggregate principal amount of the 7.930% Certificados Bursátiles due…

Davis Polk advised the underwriter in connection with a secondary offering of 12,000,000 American Depositary Shares of Hutchison China Meditech Limited (“Chi-Med”), each representing five…

Davis Polk advised the underwriters in connection with the SEC-registered Schedule B debt offerings by the Export-Import Bank of Korea (“KEXIM”) of $500 million aggregate principal amount…